These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19664211)

  • 1. Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression.
    Roth ES; Fetzer DT; Barron BJ; Joseph UA; Gayed IW; Wan DQ
    BMC Cancer; 2009 Aug; 9():274. PubMed ID: 19664211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
    Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
    J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
    Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Contrast-Enhanced CT and [
    Wagner F; Hakami YA; Warnock G; Fischer G; Huellner MW; Veit-Haibach P
    Mol Imaging Biol; 2017 Oct; 19(5):795-803. PubMed ID: 28224325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
    Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging modalities for the staging of patients with colorectal cancer.
    Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
    Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Prognostic Factors of Bone Metastasis in Patients With Colorectal Cancer.
    Kawamura H; Yamaguchi T; Yano Y; Hozumi T; Takaki Y; Matsumoto H; Nakano D; Takahashi K
    Dis Colon Rectum; 2018 Jun; 61(6):673-678. PubMed ID: 29722726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal metastases in colorectal carcinomas: a Saskatchewan profile.
    Kanthan R; Loewy J; Kanthan SC
    Dis Colon Rectum; 1999 Dec; 42(12):1592-7. PubMed ID: 10613479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
    Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
    Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer.
    Nishiyama Y; Yamamoto Y; Yokoe K; Monden T; Sasakawa Y; Tsutsui K; Satoh K; Ohkawa M
    Ann Nucl Med; 2005 Sep; 19(6):491-7. PubMed ID: 16248386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of risk factors for bone metastasis after radical resection of colorectal cancer within 5 years].
    Li A; Tan Z; Fu C; Wang H; Yuan J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):58-61. PubMed ID: 28105621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.
    Imdahl A; Reinhardt MJ; Nitzsche EU; Mix M; Dingeldey A; Einert A; Baier P; Farthmann EH
    Langenbecks Arch Surg; 2000 Mar; 385(2):129-34. PubMed ID: 10796051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of FDG PET/CT in patients with colorectal cancer metastases.
    Kochhar R; Liong S; Manoharan P
    Cancer Biomark; 2010; 7(4):235-48. PubMed ID: 21576816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.